BLCO240517P22500
- 7.80
- 0.000.00%
Bausch + Lomb Corp. Newsroom
Express News | Bausch + Lomb : Morgan Stanley Raises Target Price to $18 From $16
Express News | Bausch + Lomb : Morgan Stanley Raises to Overweight From Equal Weight
Express News | Bausch & Lomb Shares Are Trading Higher After Morgan Stanley Upgraded the Stock From Equal-Weight to Overweight and Raised Its Price Target From $16 to $18
American Airlines To Rally Around 59%? Here Are 10 Top Analyst Forecasts For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.Wedbush rai
Express News | Morgan Stanley Upgrades Bausch & Lomb to Overweight, Raises Price Target to $18
Bausch + Lomb Corporation (NYSE:BLCO) Just Reported Earnings, And Analysts Cut Their Target Price
After the latest results, the twelve analysts covering Bausch + Lomb are now predicting revenues of US$4.66b in 2024. If met, this would reflect a meaningful 8.1% improvement in revenue compared to the last 12 months.
Bausch + Lomb Corp. Is Maintained at In-Line by Evercore Partners
Bausch + Lomb Corp. Is Maintained at In-Line by Evercore Partners
Deutsche Bank Adjusts Bausch + Lomb Price Target to $14 From $18, Maintains Hold Rating
Bausch + Lomb (BLCO) has an average rating of outperform and price targets ranging from $14 to $26, according to analysts polled by Capital IQ. Price: 13.43, Change: -0.31, Percent Change: -2.28
Express News | HC Wainwright & Co. Reiterates Buy on Bausch & Lomb, Maintains $20 Price Target
Express News | Bausch + Lomb : BofA Global Research Cuts Price Objective to $18 From $20
Express News | Bausch + Lomb : Evercore ISI Cuts Target Price to $15 From $17
Earnings Call Summary | Bausch + Lomb Corp.(BLCO.US) Q1 2024 Earnings Conference
The following is a summary of the Bausch + Lomb Corporation (BLCO) Q1 2024 Earnings Call Transcript:Financial Performance:Bausch + Lomb reported Q1 revenue of $1.099 billion, up 20% in constant curren
Express News | Needham Reiterates Hold on Bausch & Lomb
Bausch & Lomb Corp (BLCO) Q1 2024 Earnings: Surpasses Revenue Estimates Amidst Net Loss Widening
Bausch + Lomb Quarterly Loss Widens
By Robb M. Stewart Bausch + Lomb's loss in the first quarter widened with a rise in interest expenses and provisions for taxes, offsetting increased product sales. The Canadian eye-health company re
Express News | Bausch + Lomb Raises Full-Year 2024 Constant Currency Revenue Growth Guidance From 12-14% To 13-15%, With Revenue Guidance Of $4.6B–$4.7B Versus Consensus Of $4.66B
Bausch & Lomb Q1 2024 Adj EPS $0.07 Beats $0.05 Estimate, Sales $1.099B Beat $1.065B Estimate
Bausch & Lomb (NYSE:BLCO) reported quarterly earnings of $0.07 per share which beat the analyst consensus estimate of $0.05 by 40 percent. This is a 30 percent decrease over earnings of $0.10 per shar
Press Release: Bausch + Lomb Announces First-Quarter 2024 Results
Bausch + Lomb Announces First-Quarter 2024 Results -- Revenue of $1.099 Billion -- GAAP Net Loss Attributable to Bausch + Lomb Corporation of $167 Million -- Adjusted EBITDA (non-GA
Wall Street Set To Open Lower After AMD Earnings Disappoint As Traders Look To Fed's Powell For Relief: Why This Analyst Sees Incoming Summer Rally
A negative sentiment might linger on Wall Street on Wednesday, as evidenced by stock futures, after Advanced Micro Devices, Inc.'s (NASDAQ:AMD) underwhelming quarterly report, exerting pressure on the
Bausch + Lomb Announces Presentation of New Data at the Association for Research in Vision and Ophthalmology Annual Meeting
21 Poster Presentations include Evaluations of Consumer, Pharmaceutical, Surgical and Vision Care Products and Pipeline Programs, Including a Novel Dry Eye Nutritional Supplement Bausch + Lomb Corporation (TSX:BLCO),